Profile image
Story Views

Last Hour:
Last 24 Hours:

RoActemra Drug Market 2016 Overview, Properties

Monday, November 7, 2016 2:21
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Publisher Drug Report, “RoActemra- Drug Insights, 2016″ highlights the RoActemra marketed details, pipeline status and the Global API Manufacturers along with the location. The Publisher’s report covers the Global Market Assessment of the RoActemra covering the total sales estimation and also provides the RoActemra sales performance during the historical period and forecast period to 2018. Publisher’s Report also covers the detailed clinical assessment of RoActemra, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, Publisher’s Report provides the SWOT analysis for the RoActemra.


For more information


Report Scope

-A review of the RoActemra based on information derived from company and industry-specific sources

-Coverage of the Marketed data of the RoActemra on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification

-Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for RoActemra with location details

-Patent Expiry Timeline and Exclusivity Details

-Route of Synthesis of the API

-Global Forecasted Sales Figure to 2018

-Qualitative and quantitative assessment of market space

-SWOT Analysis


Reasons to buy


-Evaluate the marketing status and exclusivity details of RoActemra to exploit opportunities for generic drug development opportunities.

-Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to RoActemra.

-API intelligence over RoActemra and gaining primary intelligence over Active Ingredients manufacturers across the globe.

-Understanding the chemical route of synthesis of RoActemra.

-Uncovering opportunities in the rapidly growing the US market

-Stay ahead of competition by understanding the changing competitive landscape

-Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

-Make more informed business decisions from insightful and in-depth analysis of the drug’s performance

-Obtain sales forecast for currently marketed drug for to 2018


Request Sample Copy

Table of Contents

1. DelveInsight Report Introduction

2. RoActemra Overview

2.1 Market Competition

2.3 Competitors in Development

3 Global Sales Assessment

3.1 Historical Sales of RoActemra

3.2 Forecasted Sales of RoActemra

4 Product Description

4.1 Mechanism of Action

4.2 Pharmacodynamic Properties

4.3 Pharmacokinetic Properties

5 Marketed Details

5.1 United States

5.2 Europe

6 Patent Information

6.1 Patent Numbers and Expiry Details

6.2 Patent and Exclusivity Expiry Assessment United States (US)

6.3 Patent Details

7 Route of Synthesis

8 Global API Manufacturers Assessment

8.1 The United States Drug Master File (US DMF)

8.2 The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)

8.3 The Active Pharmaceutical Ingredient (API) Manufacturers in China

8.4 The Active Pharmaceutical Ingredient (API) Manufacturers in India

9 Generic Players

10 The Pipeline Coverage

11 Clinical Trials Information

11.1 Clinical Trials by Zone

12 Company Profile

12.1 Company Summary

12.2 Company Financials

13 SWOT Analysis

14 References

15 Appendix

16 Methodology

17 Consulting Services

18 About DelveInsight

19 Contact Us

20 Disclaimer


Make an enquiry:


Contact Us:

Call: +1-646-491-9876


About us

ReportsWeb is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.